Takeda Pharmaceutical Co Ltd TKD.BE
€24.60
Last Updated: Dec 17, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Takeda Pharmaceutical Co Ltd Stock Halal?
Shariah Compliance Analysis of TKD.BE Stock
Germany Health Care Large Cap No. As of September 2026, Takeda Pharmaceutical Co Ltd (TKD.BE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Takeda Pharmaceutical Co Ltd does not pass Musaffa's business and financial screening criteria.
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. The firm focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The firm focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The firm operates in Japan, the United States, Europe, and China.
TKD.BE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Takeda Pharmaceutical Co Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Takeda Pharmaceutical Co Ltd (TKD.BE) Chart
Financial Metrics & Statements of Takeda Pharmaceutical Co Ltd (TKD.BE)
FAQ's for Takeda Pharmaceutical Co Ltd (TKD.BE)
- As of September 2026, Takeda Pharmaceutical Co Ltd TKD.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Takeda Pharmaceutical Co Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Takeda Pharmaceutical Co Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Takeda Pharmaceutical Co Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Takeda Pharmaceutical Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Takeda Pharmaceutical Co Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Takeda Pharmaceutical Co Ltd (TKD.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
